NexGoal co-owner Brad Mullins will join several other riders to form Team NexGoal as participants in the inaugural VeloSano Bike to Cure, supporting cancer research at the Cleveland Clinic.
The VeloSano (from the Latin meaning “swift” and “cure”) is modeled after the successful Pelotonia and Pan-Mass Challenge, which also benefit cancer research. Cleveland Clinic trustees Stewart A. and Donna Kohl contributed the initial $1 million dollars to establish the race in 2013.
Team NexGoal‘s members have all been touched by cancer and the money they will raise will support the basic, clinical, and translational cancer research that is done at the world renown Cleveland Clinic. 100% of all participant-raised dollars will go towards sustainable funding to support cancer research that touches cancer patients throughout northeast Ohio and the United States.
“NexGoal is proud to sponsor and participate in the VeloSano bike for cure event,” said Mullins. “We all know of someone who has suffered through or lost the battle with cancer. Both of my parents lost their lives to brain cancer so this is way for me to give back. 100% of the proceeds donated go to the Cleveland Clinic research foundation and we want to be a part of the team that can help the cause.”
The event begins Friday with the Opening Ceremony at Mall B in Cleveland, OH. Riders begin their journey Saturday, July 19 from Mall B, with several different courses available for participants. On Sunday, July 20, a day-long celebration at the Start/Finish line at Mall B will feature activities for participants and supporters alike.
Founded in 1921, the Cleveland Clinic integrates clinical and hospital care with research and education and has pioneered many medical breakthroughs. Consistently named one of U.S. News & World Report’s “America’s Best Hospitals”, it includes 75 facilities throughout northern Ohio and locations in Florida, Nevada, Canada, and Abu Dhabi.
To learn more about the event, visit www.velosano.org. Learn about Team NexGoal and make a contribution via this link.